Effects of receptor class- and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture.
暂无分享,去创建一个
[1] M. Dawson,et al. Regulation of RARβ expression by RAR‐ and RXR‐selective retinoids in human lung cancer cell lines: Effect on growth inhibition and apoptosis induction , 1998, International journal of cancer.
[2] M. Sheikh,et al. Retinoic acid nuclear receptor β inhibits breast carcinoma anchorage independent growth , 1995, Journal of cellular physiology.
[3] Norio Miyaura,et al. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds , 1995 .
[4] K. R. Ely,et al. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. , 1995, Cancer research.
[5] M. Pfahl,et al. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. , 1995, Journal of medicinal chemistry.
[6] M. Sheikh,et al. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. , 1995, Oncogene.
[7] W. Benedict,et al. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. , 1995, Journal of the National Cancer Institute.
[8] J S Lee,et al. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.
[9] K. Takeyama,et al. In vivo isomerization of retinoic acids. Rapid isomer exchange and gene expression. , 1994, The Journal of biological chemistry.
[10] M. Pfahl,et al. A specific defect in the retinoic acid response associated with human lung cancer cell lines. , 1994, Cancer research.
[11] K. R. Ely,et al. Recombinant human retinoic acid receptor beta. Binding of synthetic retinoids and transcriptional activation. , 1994, The Journal of biological chemistry.
[12] S. Guichard,et al. Response of four human ovarian carcinoma cell lines to ALL‐TRANS retinoic acid: Relationship with induction of differentiation and retinoic acid receptor expression , 1994, International journal of cancer.
[13] H. Tsou,et al. Down-Regulation of Retinoic Acid Receptor 3 in Mammary Carcinoma Cell Lines and Its Up-Regulation in Senescing Normal Mammary Epithelial Cells 1 , 2005 .
[14] M. Sporn,et al. The Retinoids : biology, chemistry, and medicine , 1994 .
[15] Pemrick Sm,et al. The retinoid receptors. , 1994 .
[16] G. Krupitza,et al. Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcription. , 1993, British Journal of Cancer.
[17] H. Koeffler,et al. 9-cis-retinoic acid : effects on normal and leukemic hematopoiesis in vitro , 1993 .
[18] P Chambon,et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Shroot,et al. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma. , 1992, Biochemical and biophysical research communications.
[20] P. Chambon,et al. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. , 1991, Cancer research.
[21] P. Chambon,et al. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. , 1991, Experimental cell research.
[22] G. Martorell,et al. DEOXYGENATION OF HIGHLY HINDERED PHENOLS , 1990 .
[23] G. Frenking,et al. Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids. , 1989, Journal of medicinal chemistry.
[24] Y. Hashimoto,et al. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. , 1988, Journal of medicinal chemistry.
[25] M. Dawson,et al. Synthesis and pharmacological activity of 6-[(E)-2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethen-1-yl]- and 6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acids. , 1983, Journal of medicinal chemistry.